Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost.
OBJECTIVE
To report a case of angiographically documented cystoid macula edema occurring after switching a pseudophakic patient from latanoprost to bimatoprost.


METHODS
Observational case report.


METHODS
A 68-year-old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to bimatoprost 9 months after cataract surgery in an eye at low-risk for this cystoid macular edema.


RESULTS
Bimatoprost was discontinued and diclofenac initiated. After 2 months, visual acuity and ocular hyperemia returned to baseline levels. Fundus examination revealed resolution of cystoid macula edema.


CONCLUSIONS
It is possible that pseudophakic eyes that develop intense conjunctival hyperemia associated with ocular hypotensive lipids might be at higher risk for developing cystoid macula edema.
Carrillo
Monica M
MM
Department of Ophthalmology, Dalhousie University, 1278 Tower Road, Halifax, Nova Scotia B3H 2Y9, Canada.
Nicolela
Marcelo T
MT
D000368:Aged; D000577:Amides; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives; D003228:Conjunctiva / Q000098:blood supply; D005451:Fluorescein Angiography; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008055:Lipids / Q000009:adverse effects*; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D019591:Pseudophakia / Q000150:complications; D012307:Risk Factors
D000577:Amides; D000959:Antihypertensive Agents; D008055:Lipids; D011461:Prostaglandins F, Synthetic; D003008:Cloprostenol; D000077338:Latanoprost; D000069580:Bimatoprost